Publications by authors named "Michael Agrez"

Claim this Profile
A
An Immunomodulating Peptide with Potential to Promote Anticancer Immunity Without Compromising Immune Tolerance.
Michael Agrez, Christopher Chandler, Amanda L Johnson, Marlena Sorensen, Kirstin Cho

Biomedicines· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-modulating nanomedicines for enhanced drug delivery to non-small-cell lung cancer.
Feifei Liu, Christopher B Howard, Pie Huda, Nicholas L Fletcher, Craig A Bell, Michael Agrez

Biomaterials· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel immunomodulating peptide with potential to complement oligodeoxynucleotide-mediated adjuvanticity in vaccination strategies.
Michael Agrez, Christopher Chandler, Kristofer J Thurecht, Nicholas L Fletcher, Feifei Liu

Sci Rep· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An immunomodulating peptide with potential to suppress tumour growth and autoimmunity.
Michael Agrez, Christopher Chandler, Kristofer J Thurecht, Nicholas L Fletcher, Feifei Liu

Sci Rep· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An immunomodulating peptide to counteract solar radiation-induced immunosuppression and DNA damage.
Michael Agrez, Mark Stephen Rybchyn, Warusavithana Gunawardena Manori De Silva, Rebecca Sara Mason, Christopher Chandler

Sci Rep· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel lipidic peptide with potential to promote balanced effector-regulatory T cell responses.
Michael Agrez, Justyna Rzepecka, Darryl Turner, Gavin Knox, Christopher Chandler

Sci Rep· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrin αvβ6 plays a bi-directional regulation role between colon cancer cells and cancer-associated fibroblasts.
Cheng Peng, Xueqing Zou, Wanying Xia, Huijie Gao, Zequn Li, Michael Agrez

Biosci Rep· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Norcantharidin Suppresses Colon Cancer Cell Epithelial-Mesenchymal Transition by Inhibiting the αvβ6-ERK-Ets1 Signaling Pathway.
Cheng Peng, Zequn Li, Zhengchuan Niu, Wei Niu, Zongquan Xu, Michael Agrez

Sci Rep· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the interaction between heterodimeric αvβ6 integrin and urokinase plasminogen activator receptor (uPAR) using functional proteomics.
Seong Beom Ahn, Abidali Mohamedali, Samyuktha Anand, Harish R Cheruku, Debra Birch, Michael Agrez

J Proteome Res· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrin αvβ6 and transcriptional factor Ets-1 act as prognostic indicators in colorectal cancer.
Cheng Peng, Huijie Gao, Zhengchuan Niu, Ben Wang, Zhen Tan, Michael Agrez

Cell Biosci· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A computer-based task management system for junior medical officers during after-hours shifts.
Nicholas J Whitehead, O'Neil N Maharaj, Michael Agrez

Med J Aust· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PKC promotes the migration of colon cancer cells by regulating the internalization and recycling of integrin αvβ6.
Jian Wang, Jingjing Wu, Jianguo Hong, Rong Chen, Kesen Xu, Michael Agrez

Cancer Lett· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Norcantharidin induces HT-29 colon cancer cell apoptosis through the alphavbeta6-extracellular signal-related kinase signaling pathway.
Cheng Peng, Xiangqun Liu, Enyu Liu, Kesen Xu, Weibo Niu, Michael Agrez

Cancer Sci· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of integrin alphaupsilonbeta6 by RNA interference in colon cancer cells inhibits extracellular matrix degradation through the MAPK pathway.
Jiayong Wang, Zhaoyang Zhang, Kesen Xu, Xiaohui Sun, Guangyun Yang, Michael Agrez

Int J Cancer· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
alpha(v)beta(6) Integrin expression in diseased and transplanted kidneys.
Paul Trevillian, Helen Paul, Ewan Millar, Adrian Hibberd, Michael V Agrez

Kidney Int· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rectal cancer masquerading as an amoeboma: case report and review of the literature.
Michael Agrez, Costa Karihaloo, Glenn Reeves, Murugasu Puvaneswary, Lucillie Sturm

ANZ J Surg· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrin expression in colon cancer cells is regulated by the cytoplasmic domain of the beta6 integrin subunit.
Jun Niu, Douglas J Dorahy, Xinhua Gu, R J Scott, Brian Draganic, Michael V Agrez

Int J Cancer· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct integrin alphavbeta6-ERK binding: implications for tumour growth.
Nuzhat Ahmed, Jun Niu, Douglas J Dorahy, Xinhua Gu, Sarah Andrews, Michael V Agrez

Oncogene· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis